2. Interventions of Chinese medicinal herbs and outcome measures.
Study ID | CMH interventions | Control intervention | Loss of HBsAg | Loss of HBeAg | Loss of HBV DNA | ALT normalisation |
Chen 2000 | Kurorinone | interferon‐alfa2a | ‐ | NS | NS | NS |
Huang 1993 | Phyllanthus amarus | non‐specific drugs | NS | + | ‐ | ‐ |
Wang 1991a | Potenlini | non‐specific drugs | NS | NS | ‐ | NS |
Wang 1994a | Polyporus umbellatus polysaccharide | non‐specific drugs | NS | + | + | ‐ |
Wang 1994a | Buqi Jiedu Tang | non‐specific drugs | NS | NS | NS | ‐ |
Xiao 1994 | Fuzheng Jiedu Tang | non‐specific drugs | + | + | + | ‐ |
Yan 1988 | Polyporus umbellatus polysaccharide | placebo | NS | + | ‐ | NS |
Yang 1986 | Kangdu Wan | placebo | NS | NS | NS | NS |
Zhang 1993a | Anisodamine plus Salvia miltiorrhiza | non‐specific drugs | NS | NS | NS | + |
Zheng 1999 | HB‐Granule‐3 (Phyllanthus compound) | interferon‐gamma | NS | NS | NS | ‐ |
+: positive ‐: not estimated NS: not significant |